Reproducibility crisis: Blame it on the antibodies
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These serum cTnI enrichment results illustrate the major benefits of functionalized NPs compared to current antibody-based approaches: (1) NPs are capable of reproducibly and effectively enriching cTnI (Supplementary Fig. 23) across all tested serum samples without the use of antibody, thus overcoming the intrinsic antibody-related limitations (vide supra)14,15,51–53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, these NPs can serve as replacements to conventional immuno-based techniques to overcome the antibody-related limitations in cTnI immunoassays and potentially address the current reproducibility crisis caused by antibodies in general14–16,51,53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Yet a recent survey found that 70% of scientists have tried and failed to reproduce results from a published experiment.1”
From Reproducibility of Quantitative Systems Pharmacology Models: Current Challenges and Future Opportunities (2019) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“However, antibodies possess many inherent limitations: batch-to-batch variation, high cost of production, poor chemical stability, and lack of proteoform-specific epitope recognition that collectively contribute to reproducibility issues [62–64].”
From Top-down proteomics: challenges, innovations, and applications in basic and clinical research (2020) · cites this paper as [63]
In the citing paper
“However, antibody-based platforms suffer from significant limitations including the batch-to-batch variability, high cost of the antibody production, and relatively low chemical stability14,15.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
Berglund, L., Björling, E., Oksvold, P., Fagerberg, L., Asplund, A., Al-Khalili Szigyarto, C., Persson, A., Ottosson, J., Wernérus, H., Nilsson, P., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800013-mcp200 · Cited by 672
Reproducibility: Standardize antibodies used in research
Bradbury, A., & Plückthun, A. (2015) · Nature · doi:10.1038/518027a · Cited by 647
Bordeaux, J., Welsh, A. W., Agarwal, S., Killiam, E., Baquero, M. T., Hanna, J. A., Anagnostou, V. K., & Rimm, D. L. (2010) · BioTechniques · doi:10.2144/000113382 · Cited by 589
An assessment of histone-modification antibody quality
Egelhofer, T. A., Minoda, A., Klugman, S., Lee, K., Kolasinska-Zwierz, P., Alekseyenko, A. A., Cheung, M.-S., Day, D. S., Gadel, S., Gorchakov, A. A., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1972 · Cited by 428
How reliable are G-protein-coupled receptor antibodies?
Michel, M. C., Wieland, T., & Tsujimoto, G. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0395-y · Cited by 306
Prassas, I., & Diamandis, E. P. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-1078 · Cited by 31
Cited by
Items 801–816 of 816
Testa, V., Cavalera, S., Nardo, F. D., Serra, T., Anfossi, L., & Baggiani, C. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7379983
Monitoring EML4-ALK Biomarkers via a Microfluidic Assay for Treatment Efficacy Assessment
Doron, S., Brio, L., Krasner, M., Barbiro‐Michaely, E., & Gerber, D. (2026) · Biosensors · doi:10.3390/bios16090484
“There are many commercially available antibodies and kits for VEGF detection [26,27].”
Harnessing in vitro models and assays for tissue engineering
Rao, E. P., & Majood, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33455-9.00006-7
Ten simple rules for suggesting reviewers during a paper submission
Schwartz, R. S., Markel, S., Palagi, P. M., & Ouellette, B. F. F. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1014780
“For example, it will grapple with larger numbers of authors in our disciplines [19], ongoing concerns about reproducibility [20], and emerging questions about the potential uses and misuses of artificial intelligence in writing and reviewing [21, 22].”
Evaluating novel antibodies for cytokine profiling in the guinea pig model
Maristela, L., Longworth, A., Ackart, D. F., Lanni, F., Gibb, J., Freedman, A., Miller, O. R., Cai, L., Qi, H., Baldwin, S. L., et al. (2026) · ImmunoHorizons · doi:10.1093/immhor/vlag051
“27 Monoclonal recombinant antibodies are highly specific, making them useful for detecting their targets in many different applications.”
Cerri, D. G., Mesquita, L. H., Praça, F. S. G., Fortes, S. S. G., Carrilho, E., & Bentley, M. V. L. B. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2738648
Reproducibility in biomedical research
Zhong, J., D’Angelo, D., Lyu, C., Xu, I., Enns, P. K., Wang, F., & Kaushal, R. (2026) · Nature Medicine · doi:10.1038/s41591-026-04667-1
“Concern about research reproducibility has been persistent since the mid-2010s when scientists first described a ‘reproducibility crisis’ 6,25–27 .”
Better antibodies, better science
Duchêne, J. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3004001
“Concerns about antibody specificity and validation have been raised for more than a decade [5,6], and the financial costs of unreliable antibodies were estimated in 2015 at $800 million wasted worldwide each year [6].”
Author response: A validated antibody toolbox for ALS research
Ayoubi, R., MacDougall, E. J., McDowell, I., Biddle, M., Ferreira, B. T., Zha, C., Dorion, M., Ross, J. P., Bolívar, S. G., Moleón, V. R., et al. (2026) · eLife · doi:10.7554/elife.111349.2.sa0
Li, Y., Wang, B., Wang, Z., Yan, W., Tang, F., & He, J. (2026) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-026-06861-z
Proteomics in Antitumor Drug Target Discovery, Toxicity, Resistance, and Precision Oncology
Zhong, Q., 吴秀丽, Wiecheć, E., Yang, Y., 廖明万, Zhou, H., Gao, S., Li, Y., Luo, S., & Xu, L. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s629658
A validated antibody toolbox for ALS researchPreprint
Ayoubi, R., MacDougall, E. J., McDowell, I., Biddle, M., Ferreira, B. T., Zha, C., Dorion, M., Ross, J. P., Bolívar, S. G., Moleón, V. R., et al. (2026) · eLife · doi:10.7554/elife.111349.2
Medenica, T., Bokulić, E., Mažuranić, A., Martinović, S., Judáš, M., & Sedmak, G. (2026) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2026.110939
FAIRsharing record for: ABCD database
FAIRsharing Team (2018) · FAIRsharing.org · doi:10.25504/fairsharing.z8oki5
Quantitative Top‐Down Proteomics: A Review
Cupp‐Sutton, K. A., Atallah, M. A., Zhao, Z., Anjum, S., Chowdhury, T., Sunny, A. T., Szamweber, P., & Wu, S. (2026) · Mass Spectrometry Reviews · doi:10.1002/mas.70051
Ning, J., Zhao, J., Jiangbin, S., & Zeng, X. (2026) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2026.119256
Metadata
- Authors
- Baker, M.
- Corresponding author
- Baker, Monya
- Venue
- Nature
- Published
- 2015-05-19
- Volume
- 521
- Issue
- 7552
- Pages
- 274-276
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1592986776
- Cited by
- 830
- References
- 7
- Citations by year
- 2026: 55 · 2025: 58 · 2024: 56 · 2023: 57 · 2022: 67 · 2021: 68 · 2020: 78 · 2019: 75 · 2018: 87 · 2017: 93 · 2016: 83 · 2015: 51
- Type
- other
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Keywords
- replication crisis, immunoglobulins, antibody validation, scientific rigor, research integrity
- MeSH terms
- Antibodies, Antibody Specificity, Cross Reactions, Humans, Indicators and Reagents, Membrane Proteins, Quality Control, Reagent Kits, Diagnostic, Reproducibility of Results, Artifacts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.